Every material Form 8-K Gabelli Healthcare & WellnessRx Trust filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
The Trust disclosed that Mario J. Gabelli, its trustee and chief investment officer, was admitted to hospital for observation and testing after a medical incident on March 19, 2026. The filing says his condition is improving but his return timeline is unknown, and Kevin V. Dreyer and Christopher J. Marangi now lead the Fund's portfolio management team in his absence.
Mario J. Gabelli was hospitalized for observation and testing after a medical incident on March 19, 2026; his return date is not yet known.
On March 22, 2026, GAMCO implemented a succession plan and named Christopher J. Marangi its President.
Kevin V. Dreyer and Christopher J. Marangi lead the Fund's portfolio management team during Mr. Gabelli's absence.
Day-to-day operations of GAMCO continue under co-CEO Douglas R. Jamieson and Christopher J. Marangi.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Gabelli Healthcare & WellnessRx Trust filing is on SEC EDGAR ↗. 8-K briefs of other companies →